Fedenia Advisers’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.87K Buy
+10
New +$3.71K ﹤0.01% 405
2026
Q1
Sell
-783
Closed -$274K 113
2025
Q4
$274K Buy
783
+18
+2% +$6.08K 0.11% 131
2025
Q3
$247K Sell
765
-104
-12% -$32.3K 0.1% 143
2025
Q2
$338K Buy
869
+131
+18% +$52.7K 0.16% 103
2025
Q1
$321K Buy
738
+80
+12% +$32.1K 0.21% 83
2024
Q4
$243K Buy
+658
New +$275K 0.14% 121

Other funds holding ELV

Fedenia Advisers's ELV Position: Q2 2026 in Review

Fedenia Advisers opened a new position in Elevance Health (ELV) in Q2 2026: 10 shares worth $3.87K. The stake represents ﹤0.01% of the portfolio and ranks #405 among its holdings. This is a return to the name: Fedenia Advisers previously reported a position in ELV as recently as Q4 2025.

Fedenia Advisers first reported a position in ELV in Q4 2024 and has held it in 6 quarters since. The position peaked at $338K in Q2 2025. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Fedenia Advisers held 10 shares of Elevance Health worth $3.87K as of Q2 2026.
  • Elevance Health was a new Fedenia Advisers position in Q2 2026.
  • Elevance Health made up ﹤0.01% of Fedenia Advisers's portfolio in Q2 2026, its #405 holding.
  • Fedenia Advisers first reported a position in Elevance Health in Q4 2024 and has held it in 6 quarters since.
  • Fedenia Advisers's Elevance Health position peaked at $338K in Q2 2025.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Fedenia Advisers's 13F filing for Q2 2026, filed 22 Jul 2026.